文献速递乳腺癌放疗

乳腺癌辅助放疗患者对侧内乳淋巴结的 incidental 剂量分布

Incidental dose distribution to contralateral internal mammary nodes in breast cancer patients undergoing adjuvant radiotherapy.
PubMed 文献 · Clin Transl Radiat Oncol · 2024-07-30

本研究评估了120例淋巴结阳性乳腺癌患者VMAT计划中对侧内乳淋巴结(cIMN)的 incidental 剂量,并按内乳淋巴结照射(IMNI)和深吸气屏气(DIBH)分组比较。结果显示cIMN-CTV平均剂量为13.0(±4.7)Gy,113/120例最大剂量<30 Gy;IMNI组平均剂量显著高于无IMNI组(14.3 Gy vs 9.6 Gy,p=0.0001),自由呼吸组高于DIBH组(13.9 Gy vs 11.2 Gy,p=0.002)。基于随机RNI试验的模拟计划显示cIMN剂量覆盖可忽略(平均剂量1.0-1.8 Gy)。

要点

  • cIMN-CTV平均 incidental 剂量为13.0(±4.7)Gy,113/120例最大剂量<30 Gy。
  • IMNI组cIMN平均剂量显著高于无IMNI组(14.3 Gy vs 9.6 Gy,p=0.0001)。
  • 自由呼吸组cIMN剂量显著高于DIBH组(13.9 Gy vs 11.2 Gy,p=0.002)。

主要发现

  • cIMN-CTV的 incidental 平均剂量(Dmean±SD)为13.0(±4.7)Gy,113/120例最大剂量<30 Gy。
  • IMNI组(n=80)cIMN-CTV平均剂量显著高于无IMNI组(n=40)(14.3 Gy vs 9.6 Gy,p=0.0001)。
  • 自由呼吸组(n=80)cIMN剂量显著高于DIBH组(n=40)(13.9 Gy vs 11.2 Gy,p=0.002)。
  • 基于随机RNI试验的模拟治疗计划显示所有方案对cIMN的剂量覆盖可忽略(平均剂量1.0-1.8 Gy)。

关键数值与推荐

  • cIMN-CTV incidental 平均剂量13.0(±4.7)Gy,113/120例最大剂量<30 Gy。
  • IMNI组cIMN-CTV平均剂量14.3 Gy vs 无IMNI组9.6 Gy(p=0.0001)。
  • 自由呼吸组cIMN剂量13.9 Gy vs DIBH组11.2 Gy(p=0.002)。
  • 基于MA20、EORTC22922/10925和AMAROS试验野设计的模拟计划cIMN平均剂量1.0-1.8 Gy。

局限性

  • 作者在结论中认为需进一步研究评估高危患者有意照射cIMN的潜在影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: In a relevant number of primary breast cancer patients, lymphatic drainage to the contralateral internal mammary nodes (cIMN) is being observed. Nevertheless, so far lymphatic drainage pathway to the cIMN is largely neglected during adjuvant radiotherapy. MATERIALS AND METHODS: This study evaluated the incidental dose to the cIMN for 120 volumetric modulated arc therapy (VMAT) treatment plans for node positive breast in dependence of internal mammary node irradiation (IMNI) and deep inspiration breath hold (DIBH). Additionally, incidental dose distribution to the cIMN based on the field design in the MA20, EORTC22922/10925 and AMAROS trials was assessed. RESULTS: The incidental dose (Dmean ± SD) to the cIMN-CTV was 13.0 (±4.7) Gy with a maximum dose of < 30 Gy in 113/120 cases. If IMNI was included (n = 80), the Dmean to the cIMN-CTV was significantly higher compared to no IMNI, but still comparably low (n = 40; 14.3 Gy vs. 9.6 Gy; p = 0.0001). Furthermore, the dose in the cIMN during free breathing (n = 80) was higher compared to DIBH (n = 40; 13.9 Gy vs. 11.2 Gy; p = 0.002).Simulated treatment plans based on the randomized RNI trials revealed neglectable dose coverage of the cIMN (Dmean 1.0-1.8 Gy) for all protocols. CONCLUSION: Neither in the randomized RNI trials nor during contemporary treatment techniques clinically relevant dose distribution to the cIMN was observed. Further studies are warranted to assess the potential impact of intended irradiation of cIMN in high-risk patients.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Behzadi ST, Duesberg M, Moser R, et al. Incidental dose distribution to contralateral internal mammary nodes in breast cancer patients undergoing adjuvant radiotherapy. Clin Transl Radiat Oncol. 2024. PMID: 39205671. doi:10.1016/j.ctro.2024.100831

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。